Motus GI Holdings Inc
NASDAQ:MOTS
Intrinsic Value
Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. [ Read More ]
The intrinsic value of one MOTS stock under the Base Case scenario is 0.324 USD. Compared to the current market price of 0.077 USD, Motus GI Holdings Inc is Undervalued by 76%.
Valuation Backtest
Motus GI Holdings Inc
Run backtest to discover the historical profit from buying and selling MOTS stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Motus GI Holdings Inc
Current Assets | 5.8m |
Cash & Short-Term Investments | 5m |
Receivables | 76k |
Other Current Assets | 723k |
Non-Current Assets | 1.5m |
PP&E | 1.2m |
Other Non-Current Assets | 264k |
Current Liabilities | 3.3m |
Accounts Payable | 1.8m |
Accrued Liabilities | 169k |
Other Current Liabilities | 1.3m |
Non-Current Liabilities | 1.3m |
Long-Term Debt | 1.2m |
Other Non-Current Liabilities | 27k |
Earnings Waterfall
Motus GI Holdings Inc
Revenue
|
319k
USD
|
Cost of Revenue
|
-569k
USD
|
Gross Profit
|
-250k
USD
|
Operating Expenses
|
-11.7m
USD
|
Operating Income
|
-11.9m
USD
|
Other Expenses
|
-960k
USD
|
Net Income
|
-12.9m
USD
|
Free Cash Flow Analysis
Motus GI Holdings Inc
MOTS Profitability Score
Profitability Due Diligence
Motus GI Holdings Inc's profitability score is 13/100. The higher the profitability score, the more profitable the company is.
Score
Motus GI Holdings Inc's profitability score is 13/100. The higher the profitability score, the more profitable the company is.
MOTS Solvency Score
Solvency Due Diligence
Motus GI Holdings Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Motus GI Holdings Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MOTS Price Targets Summary
Motus GI Holdings Inc
Ownership
MOTS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
MOTS Price
Motus GI Holdings Inc
Average Annual Return | -60.44% |
Standard Deviation of Annual Returns | 21.21% |
Max Drawdown | -100% |
Market Capitalization | 401.2k USD |
Shares Outstanding | 5 210 880 |
Percentage of Shares Shorted | 0.45% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. The company is headquartered in Fort Lauderdale, Florida and currently employs 30 full-time employees. The company went IPO on 2018-02-14. The firm is engaged in developing a medical device Pure-Vu System. Pure-Vu system consists of a workstation controller and a single-use, disposable sleeve that fits over standard and slim colonoscopes. The Pure-Vu System facilitates the cleaning of the colon during the colonoscopy procedure. Pure-Vu System integrates with standard and slim colonoscopes to enable safe and rapid cleansing during the procedure while preserving established procedural workflow and techniques by irrigating the colon and evacuating the irrigation fluid (water), feces and other bodily fluids and matter. The firm is focused on GI bleeds clinical research . The firm's subsidiaries include Motus GI Medical Technologies, Ltd. and Motus GI, LLC.
Contact
IPO
Employees
Officers
The intrinsic value of one MOTS stock under the Base Case scenario is 0.324 USD.
Compared to the current market price of 0.077 USD, Motus GI Holdings Inc is Undervalued by 76%.